Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...